Radcliffe Department of Medicine
Academic department conducting basic, translational and clinical research across cardiovascular science, diabetes and metabolism, immunology, haematology and molecular medicine. Activities include laboratory and computational research, patient-facing clinical research and accredited clinical trials unit operations; advanced imaging and spectroscopy; biobanking and accredited sample handling; single-cell and spatial tissue profiling; population-scale clinical data linkage and analytics; development of cellular and gene therapies; and support for technology translation and spinouts.
Industries
Nr. of Employees
large (251-1000)
Radcliffe Department of Medicine
Radcliffe Department of Medicine MRC Weatherall Institute of Molecular Medicine University of Oxford John Radcliffe Hospital Headington Oxford OX3 9DS
Products
Cardiovascular Sciences Research
Research focused on understanding cardiovascular diseases and developing related treatments.
Diabetes Research
Scientific investigation into the causes, prevention, and treatment of diabetes.
Endocrinology Research
Study of hormone-related diseases and disorders to improve diagnosis and treatment.
Cardiovascular Sciences Research
Research focused on understanding cardiovascular diseases and developing related treatments.
Diabetes Research
Scientific investigation into the causes, prevention, and treatment of diabetes.
Endocrinology Research
Study of hormone-related diseases and disorders to improve diagnosis and treatment.
Services
Doctoral training across the translational research spectrum for basic scientists and clinicians.
Research master's program covering the department's research areas.
Provision of fellowships and access to departmental facilities and mentorship for postdoctoral researchers and fellows.
Access to patient-facing research units including cardiovascular clinical research facilities, clinical magnetic resonance research centre, diabetes trials unit and translational units to support clinical studies and imaging phenotyping.
Human participant resource for medical research to support translational studies and sample-based research.
Provision and use of clinical trial support software including outcomes models, risk engines and clinical calculators to support trial design, analysis and clinical decision making.
Doctoral training across the translational research spectrum for basic scientists and clinicians.
Research master's program covering the department's research areas.
Provision of fellowships and access to departmental facilities and mentorship for postdoctoral researchers and fellows.
Access to patient-facing research units including cardiovascular clinical research facilities, clinical magnetic resonance research centre, diabetes trials unit and translational units to support clinical studies and imaging phenotyping.
Human participant resource for medical research to support translational studies and sample-based research.
Provision and use of clinical trial support software including outcomes models, risk engines and clinical calculators to support trial design, analysis and clinical decision making.
Expertise Areas
- Translational medicine
- Cardiovascular imaging and phenotyping
- Diabetes, endocrinology and metabolic physiology
- Genomics and computational biology
Key Technologies
- Next-generation sequencing (NGS), WES/WGS
- Single-cell genomics
- Spatial transcriptomics
- Multi-omics integration
News & Updates
Research developed an AI technology that predicts long-term risk of heart attack, heart failure or cardiac death from routine cardiac CT scans.
Announcement that a trial aiming to prevent low blood sugar in type 1 diabetes has opened to recruitment.
Announcement of approval for a study combining health data and AI methods within the precision cellular therapeutics research programme.
Announcement of first-in-class inhaled gene therapy entering human trials in the UK and Europe.
Initiation of patient procedures and operational start of integrated imaging and interventional services.
Listing and summary of spinout companies founded or co-founded by departmental investigators to translate research into innovations.
Research developed an AI technology that predicts long-term risk of heart attack, heart failure or cardiac death from routine cardiac CT scans.
Announcement that a trial aiming to prevent low blood sugar in type 1 diabetes has opened to recruitment.
Announcement of approval for a study combining health data and AI methods within the precision cellular therapeutics research programme.
Announcement of first-in-class inhaled gene therapy entering human trials in the UK and Europe.
Initiation of patient procedures and operational start of integrated imaging and interventional services.
Listing and summary of spinout companies founded or co-founded by departmental investigators to translate research into innovations.